Constellation Pharmaceuticals

General Information


We are a clinical-stage biopharmaceutical company using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. Our integrated epigenetics platform enables us to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity.

Employees: 64
Founded: 2008
Contact Information
Address 215 First Street, Suite 200, Cambridge, MA 02142, US
Phone Number (617) 714-0555
Web Address
View Prospectus: Constellation Pharmaceuticals
Financial Information
Market Cap $385.5mil
Revenues $0 mil (last 12 months)
Net Income $-56.0 mil (last 12 months)
IPO Profile
Symbol CNST
Exchange NASDAQ
Shares (millions): 4.0
Price range $15.00 - $15.00
Est. $ Volume $60.0 mil
Manager / Joint Managers J.P. Morgan/ Jefferies/ BMO Capital Markets
CO-Managers Oppenheimer
Expected To Trade: 7/19/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change